Så er der en ny video med spændende aktier fra Skandinavien.
Det er aktierne:
Fingerprint
Chemometec
Zealand Pharma
Og jeg har personligt lige købt op i to af dem.
Det er aktierne:
Fingerprint
Chemometec
Zealand Pharma
Og jeg har personligt lige købt op i to af dem.
28/10 2019 10:49 henningoslo 178409
Helt klart Braincool: kan 5-10 dobles
Se her seneste 10 minuters præsentation fra i torsdags: - gå ind efter 1 time og 36 minutter.
Har selv aktier i denne.
Se her seneste 10 minuters præsentation fra i torsdags: - gå ind efter 1 time og 36 minutter.
Har selv aktier i denne.
28/10 2019 13:27 henningoslo 178411
BrainCool AB (publ) ökar intäkterna för årets första nio månader till 3,1 MSEK, motsvarande en uppgång på 343% jämfört med samma period föregående år (0,7 MSEK).
30/10 2019 11:15 henningoslo 078476
Gennenbrud i USA for Brincool:
https://www.nordnet.dk/fullscreen/nyheder/1001258612-brain-cool-brain-cool-ab-publ-breakthrough-for-i-qool%E2%84%A2-system-on-the-us-market?instrumentId=16274944
https://www.nordnet.dk/fullscreen/nyheder/1001258612-brain-cool-brain-cool-ab-publ-breakthrough-for-i-qool%E2%84%A2-system-on-the-us-market?instrumentId=16274944
1/11 2019 10:38 henningoslo 078607
BC får nyt patent i USA: https://www.nordnet.dk/fullscreen/nyheder/1001263382-brain-cool-brain-cool-ab-publ-receives-new-patent-approval-in-usa?instrumentId=16274944
https://www.biostock.se/2019/10/braincool-okar-intakterna/?fbclid=IwAR0gyu1d9IAEoi0PkivVqB2dDdm3OtvpbTAoD6JKraM_UR1ofnDqRUvbEaE
https://www.biostock.se/2019/10/braincool-okar-intakterna/?fbclid=IwAR0gyu1d9IAEoi0PkivVqB2dDdm3OtvpbTAoD6JKraM_UR1ofnDqRUvbEaE
4/11 2019 12:52 henningoslo 178692
BrainCool AB (publ) receives order for one hundred (100) treatments of RhinoChill™ in Freiburg
BrainCool has signed a new sales agreement with the University hospital of Freiburg for a minimum of 100 treatments due for delivery before October 2020, of which the first 40 will be delivered this week. The product has now been fully implemented as standard treatment in the University Hospital"s "Standard Operating Procedures" (SOP) for cardiac arrest patients.
http://www.braincool.se/en/press-releases/
BrainCool has signed a new sales agreement with the University hospital of Freiburg for a minimum of 100 treatments due for delivery before October 2020, of which the first 40 will be delivered this week. The product has now been fully implemented as standard treatment in the University Hospital"s "Standard Operating Procedures" (SOP) for cardiac arrest patients.
http://www.braincool.se/en/press-releases/
Tak for at lægge det op! Har selv aktier i Zealand Pharma, så det er meget interessant at følge med i udviklingen, der byder på mange moderate op/nedsving.